ReviewMolecules (Basel, Switzerland)2024

Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases.

Moeka Nakashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.